Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL9562170 | 0.86 | USP2 (0.38) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL27117131 | 0.83 | — | — | |
| SCHEMBL32684282 | 0.80 | USP2 (0.40) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL2741644 | 0.79 | — | — | |
| SCHEMBL8208318 | 0.79 | — | — | |
| SCHEMBL104428 | 0.79 | — | — | |
| SCHEMBL104424 | 0.79 | — | — | |
| SCHEMBL23501590 | 0.78 | USP2 (0.37) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL28810834 | 0.78 | KMT2A (0.38) | USP2SMN1; SMN2HPGDTP53ALOX12 | |
| SCHEMBL28810831 | 0.77 | PRMT5 (0.43) | HPGDKMT2ALMNAPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809393-B2 | Injectable preparations of diclofenac and its pharmaceutically acceptable salts | TROIKAA PHARMACEUTICALS LTD (IN) | 2014-08-19 | — | — | US | claimed |
| US-20080153914-A1 | Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts | TROIKAA PHARMACEUTICALS LTD. (IN) | 2008-06-26 | — | — | US | claimed |
| EP-1848419-A2 | INJECTABLE PREPARATIONS OF DICLOFENIC AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | Troikaa Pharmaceuticals Ltd. (IN) | 2007-10-31 | — | — | EP | claimed |
| WO-2006095363-A2 | INJECTABLE PREPARATIONS OF DICLOFENIC AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | TROIKAA PHARMACEUTICALS LTD (IN) | 2006-09-14 | — | — | WO | claimed |
| US-9211251-B2 | Injectable preparations of diclofenac and its pharmaceutically acceptable salts | TROIKAA PHARMACEUTICALS LIMITED (IN) | 2015-12-15 | — | — | US | disclosed |
| US-8809393-B2 | Injectable preparations of diclofenac and its pharmaceutically acceptable salts | TROIKAA PHARMACEUTICALS LTD (IN) | 2014-08-19 | — | — | US | disclosed |
| US-20130137769-A1 | Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts | TROIKAA PHARMACEUTICALS LIMITED (IN) | 2013-05-30 | — | — | US | disclosed |
| CN-101123957-B | Diclofenac and Injectable preparations of pharmaceutically acceptable salts of diclofenac | TROIKAA PHARMACEUTICALS LTD | 2010-12-08 | — | — | CN | disclosed |
| US-20080153914-A1 | Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts | TROIKAA PHARMACEUTICALS LTD. (IN) | 2008-06-26 | — | — | US | disclosed |
| CN-101123957-A | Injectable preparations of diclofenic and its pharmaceutically acceptable salts | TROIKAA PHARMACEUTICALS LTD (IN) | 2008-02-13 | — | — | CN | disclosed |
| EP-1848419-A2 | INJECTABLE PREPARATIONS OF DICLOFENIC AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | Troikaa Pharmaceuticals Ltd. (IN) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006095363-A2 | INJECTABLE PREPARATIONS OF DICLOFENIC AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | TROIKAA PHARMACEUTICALS LTD (IN) | 2006-09-14 | — | — | WO | disclosed |
| EP-0823744-B1 | Ionically conductive polymeric gel electrolyte and solid battery containing the same | MITSUI CHEMICALS INC (JP) | 2005-10-12 | — | — | EP | disclosed |
| US-6013393-A | LITHIUM SULFONATE FOR BATTERIES | RICOH COMPANY, LTD. (JP) | 2000-01-11 | — | — | US | disclosed |
| US-5925283-A | HIGH IONIC CONDUCTIVITY AND HIGH SOLID STRENGTH; CROSSLINKED POLYMER MATRIX, ELECTROLYTIC SALT, AND A NONAQUEOUS ELECTROLYTIC SOLUTION WHICH CONTAINS AT LEAST ONE HALOGEN-SUBSTITUTED CARBONIC ESTER | MITSUI CHEMICALS, INC. (JP) | 1999-07-20 | — | — | US | disclosed |
| EP-0823744-A2 | Ionically conductive polymeric gel electrolyte and solid battery containing the same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |